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Objective. To evaluate the association between diabetes mellitus and health-related quality of life (HRQOL) controlled for several
sociodemographic and anthropometric variables, in a representative sample of the Spanish population. Methods. A population-
based, cross-sectional, and cluster sampling study, with the entire Spanish population as the target population. Five thousand
and forty-seven participants (2162/2885 men/women) answered the HRQOL short form 12-questionnaire (SF-12). The physical
(PCS-12) and the mental component summary (MCS-12) scores were assessed. Subjects were divided into four groups according
to carbohydrate metabolism status: normal, prediabetes, unknown diabetes (UNKDM), and known diabetes (KDM). Logistic
regression analyses were conducted. Results. Mean PCS-12/MCS-12 values were 50.9 ± 8.5/47.6 ± 10.2, respectively. Men had
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higher scores than women in both PCS-12 (51.8 ± 7.2 versus 50.3 ± 9.2; P < 0.001) and MCS-12 (50.2 ± 8.5 versus 45.5 ± 10.8;
P < 0.001). Increasing age and obesity were associated with a poorer PCS-12 score. In women lower PCS-12 and MCS-12 scores
were associated with a higher level of glucose metabolism abnormality (prediabetes and diabetes), (P < 0.0001 for trend), but
only the PCS-12 score was associated with altered glucose levels in men (P < 0.001 for trend). The Odds Ratio adjusted for age,
body mass index (BMI) and educational level, for a PCS-12 score below the median was 1.62 (CI 95%: 1.2–2.19; P < 0.002) for
men with KDM and 1.75 for women with KDM (CI 95%: 1.26–2.43; P < 0.001), respectively. Conclusion. Current study indicates
that increasing levels of altered carbohydrate metabolism are accompanied by a trend towards decreasing quality of life, mainly in
women, in a representative sample of Spanish population.
1. Introduction
Diabetes mellitus is a disease that has a serious impact on the
public health, owing to its high prevalence and its association
with chronic complications [1].
Recently published data in our country indicate an
increase in the prevalence of diabetes mellitus, so that the
13.8% of the population over 18 years of age suﬀers from
diabetes, whereas the 30% presents either impaired fasting
glucose or impaired glucose tolerance [2]. It induces a
considerable economic burden for the national health system
and for the society, as well as a detriment on quality of life.
Its association to comorbid conditions and complications
represents an opportunity to evaluate the influence of a
chronic disease on health-related quality of life (HRQOL).
Several studies have reported deterioration in the HRQOL of
diabetic patients, particularly as far as their physical function
and well-being are concerned, but also in terms of mental
health [3–7]. Available data in Spain are scarce and they
have been obtained in clinic-based studies or in selected
populations, and the outcomes have been inconclusive [8–
10]. To improve HRQOL of the diabetic patients remains
as an important target of the diabetes management. Beyond
development of optimal medication, treatment strategies
should take HRQOL and psychosocial aspects into account.
In this study, we evaluate the association between the
status in carbohydrate metabolism and HRQOL, controlled
for socio-demographic and anthropometric variables, such
as age, gender, bodymass index (BMI), and educational level,
in a large representative sample of the Spanish population.
Data obtained could be useful to plan patient-based health
decisions. The development of appropriate educational
interventions could improve patients’ ability to control their
disease, thus, resulting in an improvement in quality of life.
These results should also be used as reference values to
compare HRQOL in other chronic diseases and compared
across countries.
2. Research Design andMethods
2.1. Population. The di@betes study is a national, cross-
sectional study designed to estimate the prevalence of Dia-
betes mellitus in Spain. Data collection took place between
2009 and 2010.
The participants were invited to attend a single exami-
nation visit at their health centre. Information was collected
using a structured, interviewer-administered questionnaire,
followed by a physical examination. Fieldwork was under-
taken by seven teams, comprising a nurse and dietician.
After the interview, a fasting blood sample was obtained
and a standard OGTT was performed. Subjects with baseline
capillary blood glucose levels lower than 7.8mmoL/L and
not receiving treatment for diabetes underwent a standard
OGTT, obtaining fasting and 2 h venous samples.
Of the eligible adults, 61.7% (9653) were localized, and
55.8% (5728) attended for examination. Of these, 9.9%
were excluded by protocol (institutionalized, serious disease,
pregnant, or recent delivery), and 5072 completed the study.
Response rate of the study was a 55.8%. Diﬀerences in age
and gender were not found between responders and no
responders. A comprehensive description of the methodol-
ogy has been previously reported [2]. People who did not
complete the survey or whose data were incomplete were
excluded (n = 25). The present study includes 5047 subjects,
aged between 18 and 90 years, who responded to the HRQOL
questionnaire SF-12 (2162 men and 2885 women, with a
mean age of 50.5 ± 17.3 and 50.4 ± 16.8, resp.).
2.1.1. Assessment of Quality of Life. The SF-12 (version 1),
validated for use in the Spanish population, was used [7,
11, 12]. After its application by a trained interviewer, two
summary scales are assessed, the PCS-12 and the MCS 12.
These scales have been standardized to a mean score of 50
and a standard deviation of 10 in the general population. The
MCS and PCS scores range from 0 to 100, with lower scores
indicating lower HRQOL. A higher score in the respective
summary scales indicates a higher quality of life [12–14]. The
questionnaire was administered and supervised by a trained
nutritionist (by interview).
Information regarding self-rated health was obtained
from the question “Would you say that in general your health
is excellent, very good, good, regular or poor?”, which is one
of the twelve items included in SF-12.
Carbohydrate status was evaluated by measuring plasma
fasting glucose and/or the oral glucose tolerance test, follow-
ing the 1999 WHO criteria [15]. The population was divided
into the following groups: normal carbohydrate metabolism,
prediabetes (impaired fasting glucose and/or impaired glu-
cose tolerance), unknown diabetes mellitus (UNKDM), or
known diabetes mellitus (KDM) (in the group of KDM the
prevalence of type 1 diabetes is expected to account for only
5–10% of the sample, the same percentage described in the
literature) [16].
Body mass index (BMI, kg/m2) was classified into four
groups: normal weight (BMI < 25 kg/m2), overweight (BMI
between 25 and 29.9 kg/m2), obesity (BMI 30–39.9 kg/m2),
andmorbid obesity (BMI≥ 40 kg/m2). Educational level was
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estimated based on the highest degree completed and divided
into four groups: no studies, elementary school, secondary
school education, and university degree. The duration of
diabetes mellitus was divided into 3 categories: <5 years,
between 5 and 15 years, and >15 years.
The presence of chronic complications was defined as
self-reported history of cardiac complications (angina pec-
toris or myocardial infarction), stroke or circulatory disor-
ders of the legs.
2.2. Statistical Study. Qualitative variables were summarized
by their frequency distribution as well as quantitative var-
iables by their mean and standard deviation (mean ± SDM).
To compare the continuous variables PCS 12 and MCS 12
between more than two groups, the one-way analysis of
variance (ANOVA) for quantitative normally distributed
variables was used. If a significant diﬀerence between the
groups in ANOVA was obtained, the statistical significance
of multiple comparisons was evaluated by using a Bonferroni
correction method.
Associations between quality of life (PCS and MCS) and
glucose metabolism status were evaluated by fitting logistic
regression analysis. PCS and MCS were used as dependent
variables, categorized by the sample’s median. Three models
are reported: the first one shows the crude rates of associa-
tion, the second one reports measurements adjusted for age,
and the third one shows data adjusted for age, BMI, and
educational level. The three models are stratified by gender.
Moreover, the eﬀect of gender in the association between
glucose metabolism and quality of life was evaluated by
introducing this term of interaction into the models.
Null hypothesis was rejected by a type I error minor
than 0.05 (α < 0.05). Process and analysis of the data were
performed using the Statistical Package SPSS version 15.0 for
Windows (SPSS, Chicago, IL, USA).
3. Results
The PCS 12 value was 50.9 ± 8.5 and the MCS 12 was 47.6 ±
10.2 (mean± SDM). To the question “Howwould you define
your general health?” 2.3% of the population declared having
excellent health, 9% very good, 62.5% good, 22.9% regular,
and 3.3% poor health.
Men had higher scores than women in both PCS 12 (51.8
± 7.2 versus 50.3 ± 9.2; P < 0.001) and MCS 12 (50.2 ± 8.5
versus 45.5 ± 10.8; P < 0.001).
The scores for PCS 12 andMCS 12 according to age, BMI,
educational level, and status of carbohydrate metabolism,
stratified by gender, are shown in Table 1.
A progressive deterioration of PCS 12 was observed, as
major alterations in carbohydrate metabolism appeared but
diﬀerences in the mental scale were not found in men.
After adjusting for age, BMI, and educational level (using
a logistic regression model), this study found that physical
health was considerably lower in people with KDM (men and
women) when compared to the population with a normal
glucose metabolism. The odds ratio for a PCS-12 score below
the median was 1.62 (CI 95%: 1.2–2.19; P < 0.002) for men
with KDM and 1.75 for women with KDM (CI 95%: 1.26–
2.43; P < 0.001), respectively (Table 2). Worse HRQOL was
defined as having a score inferior than median value, taking
in mind that no optimal cut point to diﬀerentiate between
bad and good quality of life has been established for Spanish
population. Median values for PCS 12 and MCS 12 were
54.46 and 50.49, respectively. No diﬀerences in mental health
were found between groups.
There was no statistically significant interaction between
gender and glucose metabolism in any of the models.
In the KDM group, we evaluated the influence of the
treatment with insulin, duration of diabetes, and the pres-
ence of macrovascular complications in quality of life. PCS
12 was lower in insulin-treated patients as compared with
untreated diabetic patients (42.7 ± 11.3 versus 48.2 ± 9.7; P
< 0.001), in the group of patients who referred at least one
chronic complication (43.2 ± 11.0 versus 47.7 ± 9.9; P <
0.001), and in diabetes of more than 15 years of duration as
compared to those with <5 years length (44.7 ± 10.3 versus
48.1 ± 10.2; P < 0.04). Diﬀerences in mental scales were not
found.
4. Discussion
This study estimates diﬀerences in HRQOL according to sta-
tus in carbohydrate metabolism, stratified by several demo-
graphic factors, for the first time in a large and representative
sample of the Spanish population.
Taking into account the influence of anthropometric and
demographic factors, gender is one of the most important
factors when studying HRQOL. As expected, women referred
a poorer HRQOL than men, regardless of age range or BMI
status, in both physical andmental scales. This finding is con-
sistent with previous research [7–9, 17].
A remarkable decrease in the physical scales was observed
in the older population, which could be explained by the
loss of physical abilities associated with ageing. However, in
the mental scales a stabilization or slight improvement was
found in the elderly. It has been hypothesized that older peo-
ple may achieve greater emotional control responsiveness to
negative emotions. These findings are consistent with data
previously reported the in Spanish population [7–9]. Body
weight is one of the modifiable risk factors that could aﬀect
HRQOL. Ford et al. [18] found that physical function was
more strongly aﬀected than mental function in obese
patients. Our study showed similar findings inmen, although
women showed deterioration in both scores, indicating once
more that the way in which HRQOL is reported is highly in-
fluenced by gender.
This study found a decrease in the physical score asso-
ciated with more severe alterations in carbohydrate meta-
bolism. This trend is observed in the mental sphere as well,
but only in women. Unexpectedly, after adjusting for diﬀer-
ent confounding factors, no diﬀerences were found between
the normal group and the UNKDM population. These data
could suggest that the diagnosis of diabetes mellitus and
the consequent modifications in life style and/or treatment
would suppose a negative impact, modifying the perceived
HRQOL of patients.
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Table 1: PCS 12 and MCS 12 scores stratified by age, BMI, educational level, and glucose metabolism status.
N PCS 12 score MCS 12 score
M/W M W M W
Age (years)
18–30 305/367 54.9 ± 4.7 53.5 ± 6.5 49.5 ± 8.2 46.1 ± 9.9
31–45 597/849 53 ± 6.1 52.9 ± 6.9 49.5 ± 8.7 45.9 ± 10.2
46–60 575/814 51.5 ± 7.3 50.3 ± 9.2 49.7 ± 8.9 44.9 ± 11.4
61–75 493/605 50.6 ± 7.9 47.9 ± 1 51.8 ± 8.4 45.3 ± 11.4
≥76 192/250 47.7 ± 9.1 43.3 ± 11.8 51.9 ± 7.5 46.7 ± 11.2
SS: ANOVA P < 0.0001 P < 0.0001 P < 0.0001 NS
BMI (kg/m2)
<25 442/1034 52.9 ± 6.9 52.8 ± 7 49.8 ± 8.9 47.2 ± 9.6
25–29 1027/980 52.4 ± 6.6 50.6 ± 9 50.3 ± 8.2 45 ± 11.2
30–39 638/767 50.6 ± 7.8 47.8 ± 10.3 50.5 ± 8.9 44.7 ± 11.4
≥40 46/91 46.1 ± 10.2 42 ± 12 50.4 ± 9.4 40.5 ± 13.5
SS: ANOVA P < 0.0001 P < 0.0001 NS P < 0.0001
Educational level
No studies 254/404 49.8 ± 8.7 45.6 ± 10.9 50.4 ± 8.8 44.1 ± 11.9
Elementary 755/1082 51.2 ± 7.6 49.4 ± 9.8 50.5 ± 8.9 44.8 ± 11.5
Secondary education 815/950 52.4 ± 6.9 52.1 ± 7.6 50 ± 8.7 46.1 ± 10.1
University degree 338/448 53.6 ± 5.3 53.2 ± 6.9 50.3 ± 7.2 47.6 ± 9.4
SS: ANOVA P < 0.0001 P < 0.001 NS P < 0.001
Glucose metabolism status
Normal 1501/2243 52.7 ± 6.5∗ 51.4 ± 8.4 # 50.2 ± 8.3 46 ± 10.6+
Prediabetes 276/306 50.6 ± 8∗∗ 48.3 ± 10.1## 50.6 ± 9.1 43.7 ± 11.5
Unknown diabetes 140/103 49.9 ± 8.4 46 ± 11.1 49.8 ± 9.3 43.7 ± 11.8
Known diabetes 245/233 48.8 ± 8.8 44.6 ± 11.5 50.9 ± 9.3 44.5 ± 11.8
SS: ANOVA P < 0.0001 P < 0.0001 NS P < 0.0001
PCS 12, the physical summary component score. MCS 12, the mental summary component score. Pre-diabetes, IFG (impaired fasting glucose) and/or ITG
(impaired glucose tolerance). Results expressed as mean ± SD; M/W, (men/women); NS (nonsignificant).
SS: ANOVA evaluates intragroup diﬀerences for age, BMI, educational level, and glucose metabolism status.
∗P < 0.001, #P < 0.001 denote diﬀerences between normal and all of the groups (prediabetes, UKDM, and KDM).
∗∗P < 0.02 denote pre-diabetes versus known diabetes.
##P < 0.001 denote pre-diabetes versus known diabetes.
+P < 0.03 denote normal versus pre-diabetes.
SF 12 scores previously reported in a German cohort of
patients with diabetes are lower than those reported in this
study [19] (MCS 12 was 45.8 ± 10.3 and PCS 12 was 38.9 ±
9.8). However, in this paper, 36.0% of the participants had
one or more missing items in the SF-12 questionnaires, and
to deal with the missing data, they applied a modified regres-
sion estimation method. Besides, people included in the
study were older (aged 50 to 74 years) than those included in
our sample. Similarly, another study [17] carried out in
German population also found worse physical quality of life
in diabetic population, reporting slightly lower PCS 12 values
than our study, but higher MCS 12 values. Again, population
in this study was older than in our study (58.8 versus
50.4 years old), fact that could explain the discordance. In
addition, the questionnaire in our study was applied by a
trained interviewer in order to avoid “missing values.”
According to our data, the presence of chronic compli-
cations, the treatment with insulin, and a prolonged course
of the disease (over 15 years) decrease physical HRQOL in
KDM. The presence of complications is probably the most
important factor influencing the HRQOL of diabetic patients
[20]. Duration of the disease has a variable eﬀect and might
not be such an important factor [3]. Regarding the eﬀects
of treatment, the results obtained so far are not conclusive
[4, 18, 20, 21]. The present study found lower scores in the
insulin-treated group. Unfortunately, multivariate analyses
were not done because of small sample size.
Several studies that evaluate HRQOL in subjects with
diabetes have been recently published in the Spanish popula-
tion [22, 23]. In the first study [22], the variables that deter-
mined a poorer perception of HRQL among diabetic patients
were female gender, older age, obesity, lack of physicalz exer-
cise, coexistence of depression, and cerebrovascular diseases.
The other study [23] reported that the variables associated
with an increased risk of self-rated fair or poor health in
diabetic patients were age 54–64 years or ≥65 years, presence
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Table 2: Odds ratios for PCS 12 and MCS 12 scores lower than the median (Model 1) adjusted for age (Model 2), and adjusted for age,
educational level, and BMI, all stratified by gender (Model 3).
SCHOM
PCS 12 MCS 12
OR 95% IC P value OR 95% IC P value
Model 1
Normal 1 1
Prediabetes
Men 1.54 1.19–1.99 0.001 0.92 0.7–1.2 0.534
Women 1.72 1.34–2.19 0.000 1.24 0.97–1.59 0.089
UNKDM
Men 1.59 1.12–2.25 0.09 1.16 0.82–1.65 0.404
Women 2.09 1.38–3.17 0.01 1.31 0.87–1.99 0.196
KDM
Men 2.45 1.85–3.25 0.000 0.81 0.61–1.08 0.152
Women 3.11 2.29–4.21 0.000 1.04 0.79–1.37 0.761
Model 2
Normal 1 1
Prediabetes
Men 1.25 0.96–1.63 0.105 1.02 0.78–1.35 0.878
Women 1.33 1.03–1.71 0.029 1.33 1.03–1.72 0.027
UNKDM
Men 1.23 0.86–1.77 0.251 1.32 0.92–1.89 0.135
Women 1.46 0.95–2.23 0.085 1.46 0.96–2.23 0.080
KDM
Men 1.83 1.36–2.46 0.000 0.94 0.69–1.27 0.692
Women 2.15 1.56–2.95 0.000 1.16 0.87–1.55 0.321
Model 3
Normal 1 1
Prediabetes
Men 1.17 0.89–1.53 0.265 1.05 0.80–1.39 0.722
Women 1.10 0.84–1.43 0.487 1.21 0.93–1.57 0.156
UKDM
Men 1.07 0.74–1.54 0.719 1.35 0.93–1.95 0.113
Women 1.12 0.73–1.74 0.601 1.33 0.86–2.05 0.197
KDM
Men 1.62 1.2–2.19 0.002 0.95 0.7–1.30 0.765
Women 1.75 1.26–2.43 0.001 1.01 0.75–1.37 0.927
PCS 12, the physical component summary score. MCS 12, the mental component summary score. SCHOM, status of the carbohydrate metabolism.
“Prediabetes” includes impaired fasting glucose and impaired glucose tolerance. UNKDM, unknown diabetes mellitus. KDM, known diabetes mellitus.
of comorbidity, female sex, lower educational level, obesity,
and no physical activity. Current study shows the OR for
having a PCS-12 score below the median, adjusted for age,
BMI, and educational level. After adjusting for all these
factors, the group of KDM, both men and women, has
considerably worse physical quality of life.
The present study has some limitations. Unfortunately
HbA1c data were not assessed and therefore it is not possible
to estimate HRQOL as a function of glycemic control.
Another possible bias is that the institutionalized popu-
lation was not included in the sample. This group could have
a worse health status than the noninstitutionalized one.
In summary, to our knowledge, this study is the largest
report of HRQOL stratified by carbohydrate metabolism
status in a representative sample of the Spanish population.
It provides a comprehensive insight into objective and
subjective factors that may aﬀect HRQOL in patients with
diabetes. Data obtained could be helpful in establishing
health programs in diabetic populations to evaluate more
precisely self-perception of health or creating educational
projects to improve psychological well-being. It will also be
useful for comparing data obtained from patients with other
chronic diseases and across countries.
Authors’ Contributions
All the authors contributed to the interpretation of data,
discussion of results, and critical review, and they gave final
6 International Journal of Endocrinology
approval of the last version to be published. None declare
duality of interests associated with the paper.
Acknowledgments
The authors wish to acknowledge the kind collaboration of
the following entities: The Spanish Diabetes Society, the
Spanish Diabetes Federation, and the Ministry of Health
Quality Agency. The autjors’ profound appreciation goes to
the primary caremanagers and personnel of the participating
health centers, as well as to Dr. Luis Forga and Dr. Felipe
Casanueva for their inestimable help in the management of
the Northern zone. Thanks to all the field workers, nurses,
and dieticians (I. Alonso, A. Arocas, R. Badia, C.M. Bixquert,
N. Brito, D. Chaves, A. Cobo, L. Esquius, I Guille´n, E. Man˜as,
A. M. Megido, N. Ojeda, R. M. Suarep, and M. D. Zomen˜o),
without their work the study would not have been possible to
carry out and to all the people who voluntarily participated
in the study.
References
[1] J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of
the prevalence of diabetes for 2010 and 2030,” Diabetes Re-
search and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010.
[2] F. Soriguer, A. Goday, A. Boch et al. et al., “Prevalence of
diabetesmellitus and impaired glucose regulation in Spain: the
Di@bet.es Study,” Diabetologia, vol. 55, pp. 88–93, 2012.
[3] A. L. Stewart, S. Greenfield, R. D. Hays et al., “Functional sta-
tus and well-being of patients with chronic study. Results from
the medical outcomes study,” Journal of the American Medical
Association, vol. 262, no. 7, pp. 907–913, 1989.
[4] R. R. Rubin and M. Peyrot, “Quality of life and diabetes,”
Diabetes/Metabolism Research and Reviews, vol. 15, pp. 205–
218, 1999.
[5] D. J. Wexler, R. W. Grant, E. Wittenberg et al., “Correlates of
health-related quality of life in type 2 diabetes,” Diabetologia,
vol. 49, no. 7, pp. 1489–1497, 2006.
[6] P. W. Sullivan, V. Ghushchyan, H. R. Wyatt, E. Q. Wu, and
J. O. Hill, “Impact of cardiometabolic risk factor clusters on
health-related quality of life in the U.S,” Obesity, vol. 15, no. 2,
pp. 511–521, 2007.
[7] S. Ali, M. Stone, T. C. Skinner, N. Robertson, M. Davies, and
K. Khunti, “The association between depression and health-
related quality of life in people with type 2 diabetes: a sys-
tematic literature review,” Diabetes/Metabolism Research and
Reviews, vol. 26, no. 2, pp. 75–89, 2010.
[8] G. Vilagut, J. M. Valderas, M. Ferrer, O. Garin, E. Lo´pez-
Garcı´a, and J. Alonso, “Interpretation of SF-36 and SF-12
questionnaires in Spain: physical and mental components,”
Medicina Clinica, vol. 130, no. 19, pp. 726–735, 2008.
[9] G. Vilagut, M. Ferrer, L. Rajmil et al., “The Spanish version of
the Short Form 36 Health Survey: a decade of experience and
new developments,” Gaceta Sanitaria, vol. 19, no. 2, pp. 135–
150, 2005.
[10] E. Lo´pez-Garcı´a, J. R. Banegas, A. G. Pe´rez-Regadera, J. L.
Gutie´rrez-Fisac, J. Alonso, and F. Rodrı´guez-Artalejo, “Pop-
ulation-based reference values for the Spanish version of the
SF-36 Health Survey in the elderly,”Medicina Clinica, vol. 120,
no. 15, pp. 568–573, 2003.
[11] B. Gandek, J. E. Ware, N. K. Aaronson et al., “Cross-validation
of item selection and scoring for the SF-12 Health Survey in
nine countries: results from the IQOLA Project,” Journal of
Clinical Epidemiology, vol. 51, no. 11, pp. 1171–1178, 1998.
[12] “Normas poblacionales de referencia de la versio´n espan˜ola del
SF 12 versio´n 1,” Instituto Municipal de Investigacio´n Me´dica,
Barcelona, Spain, http://iryss.imim.es/iryss/BiblioPRO.asp.
[13] J. E.Ware,M. Kosinski, and S. D. Keller, “A 12-item short-form
health survey: construction of scales and preliminary tests of
reliability and validity,” Medical Care, vol. 34, no. 3, pp. 220–
233, 1996.
[14] J. E.Ware, M. Kosinski, and S. D. Keller, SF-12: How to score the
SF-12 Physical and Mental Health Summary Scales, The Health
Assessment Lab, Boston, Mass, USA; Quality Metric, Lincoln,
RI, USA, 3rd edition, 1998.
[15] WHO Consultation, “Definition, diagnosis and classification
of diabetes mellitus and its complications. I. Diagnosis and
classification of diabetes mellitus,” Report of a WHO Con-
sultation, World Health Organization, Geneva, Switzerland,
1999.
[16] American Diabetes Association, “Diagnosis and classification
of diabetes mellitus,” Diabetes Care, vol. 31, supplement 1, pp.
S55–S60, 2008.
[17] M. Schunk, P. Reitmeir, S. Schipf et al., “Health-related quality
of life in subjects with and without type 2 diabetes: pooled
analysis of five population-based surveys in Germany,” Dia-
betic Medicine, vol. 29, no. 5, pp. 646–653, 2012.
[18] E. S. Ford, D. G. Moriarty, M. M. Zack, A. H. Mokdad, and
D. P. Chapman, “Self-reported body mass index and health-
related quality of life: findings from the Behavioral Risk Factor
Surveillance System,”Obesity Research, vol. 9, no. 1, pp. 21–31,
2001.
[19] I. Maatouk, B. Wild, D. Wesche et al., “Temporal predictors
of health-related quality of life in elderly people with diabetes:
results of a German cohort study,” PLoS ONE, vol. 7, Article
ID e31088, 2012.
[20] Z. Mehta, C. Cull, I. Stratton et al., “Quality of life in type 2
diabetic patients is aﬀected by complications but not by inten-
sive policies to improve blood glucose or blood pressure con-
trol (UKPDS 37),”Diabetes Care, vol. 22, no. 7, pp. 1125–1136,
1999.
[21] C. Bradley and J. Speight, “Patient perceptions of diabetes
and diabetes therapy: assessing quality of life,” Diabetes/Meta-
bolism Research and Reviews, vol. 18, supplement 3, pp. S64–
S69, 2002.
[22] M. M. Esteban y Pen˜a, V. Hernandez Barrera, X. Ferna´ndez
Cordero et al., “Self-perception of health status, mental health
and quality of life among adults with diabetes residing in a
metropolitan area,”Diabetes andMetabolism, vol. 36, no. 4, pp.
305–311, 2010.
[23] R. Jime´nez-Garcia, I. Jime´nez-Trujillo, V. Hernandez-Barrera,
P. Carrasco-Garrido, A. Lopez, and G. Angel, “Ten-year trends
in self-rated health among Spanish adults with diabetes, 1993–
2003,” Diabetes Care, vol. 31, no. 1, pp. 90–92, 2008.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
